| 0 (0%) | 11-30 07:30 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 22.75 | 1-year : | 26.57 |
| Resists | First : | 19.47 | Second : | 22.75 |
| Pivot price | 16.62  |
|||
| Supports | First : | 15.94 | Second : | 13.76 |
| MAs | MA(5) : | 18.6 |
MA(20) : | 16.21 |
| MA(100) : | 16.39 |
MA(250) : | 17.83 |
|
| MACD | MACD : | 0.9 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 96.1 |
D(3) : | 96.2 |
| RSI | RSI(14): 73.6 |
|||
| 52-week | High : | 25.67 | Low : | 13.5 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ ADMA ] has closed below upper band by 9.0%. Bollinger Bands are 162.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 19.5 - 19.59 | 19.59 - 19.66 |
| Low: | 18.76 - 18.9 | 18.9 - 18.98 |
| Close: | 18.95 - 19.15 | 19.15 - 19.28 |
Wed, 05 Nov 2025
ADMA Biologics Inc (ADMA) Q3 2025 Earnings Call Highlights: Record Growth and Strategic Advancements - Yahoo Finance
Mon, 15 Sep 2025
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Mon, 15 Sep 2025
Polyphenol‐Mediated Engineering of Lipid Nanoparticles With Crystalline Mesophases - Wiley
Wed, 03 Sep 2025
Peptide Coacervates with Metal–Phenolic Membranes Modulate Glucose Metabolism and Enhance Cancer Immunotherapy - Wiley
Tue, 19 Aug 2025
Solar-Driven Atmospheric Water Production Through Hierarchically Ordered Porous Carbon for Self-Sustaining Green Hydrogen Production - Wiley
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 238 (M) |
| Shares Float | 233 (M) |
| Held by Insiders | 2.5 (%) |
| Held by Institutions | 96.3 (%) |
| Shares Short | 16,650 (K) |
| Shares Short P.Month | 17,410 (K) |
| EPS | 0.86 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.8 |
| Profit Margin | 42.8 % |
| Operating Margin | 38 % |
| Return on Assets (ttm) | 21.7 % |
| Return on Equity (ttm) | 63.1 % |
| Qtrly Rev. Growth | 12 % |
| Gross Profit (p.s.) | 1.12 |
| Sales Per Share | 2.05 |
| EBITDA (p.s.) | 0.73 |
| Qtrly Earnings Growth | -0 % |
| Operating Cash Flow | 65 (M) |
| Levered Free Cash Flow | 3 (M) |
| PE Ratio | 22.28 |
| PEG Ratio | 0 |
| Price to Book value | 10.58 |
| Price to Sales | 9.33 |
| Price to Cash Flow | 70.2 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|